Amsterdam-based European life sciences VC with 35+ year track record and €3.5B raised across 12 funds. Part of EQT Group since 2022. Backs innovative healthcare companies from seed to late stage across Europe and US.
Auto-extracted from press releases.
Auto-detected from LSP (EQT Life Sciences)'s website.
Partner heading the Dementia Fund focused on drug development for neurodegenerative diseases.
Head of EQT Life Sciences with deep experience in life sciences investing and portfolio company guidance.
Partner leading health economic funds focused on later-stage MedTech and digital health investments.
Focus and check size from the firm's website. Website reachable as of Aug 2026.
A fit check scores your pitch against their thesis, stage and ticket. An email draft uses their real deals and thesis, not a template.